- Aptevo Therapeutics Inc APVO shares climbed 65.4 percent to $2.20. Aptevo Therapeutics reported end of joint development and commercialization deal with MorphoSys for MOR209/ES414 and disclosed a $74.5 million agreement to sell hyperimmune commercial products.
- Amira Nature Foods Ltd ANFI shares jumped 17.1 percent to $6.24.
- Orchids Paper Products Company TIS shares surged 16.9 percent to $11.92 after the company disclosed that it has won a new business from a customer in 'a new distribution channel.'
- TRACON Pharmaceuticals Inc TCON shares rose 16 percent to $2.90.
- Strattec Security Corp. STRT climbed 13.2 percent to $35.55 after gaining 2.11 percent on Thursday.
- Calumet Specialty Products Partners, L.P CLMT shares jumped 11.6 percent to $8.93.
- Iovance Biotherapeutics Inc IOVA shares surged 11.3 percent to $6.40 as the company disclosed that the FDA has granted Fast Track designation for LN-144.
- Opiant Pharmaceuticals Inc OPNT shares rose 10.3 percent to $39.13.
- Palo Alto Networks Inc PANW climbed 9.5 percent to $145.22 as the company posted stronger-than-expected results for its fourth quarter and announced the retirement of its Chief Financial Officer Steffan Tomlinson. JP Morgan upgraded Palo Alto from Neutral to Overweight, while First Analysis upgraded the stock from Equal Weight to Overweight.
- Xenetic Biosciences Inc XBIO shares rose 9.5 percent to $2.65.
- Oxford Industries Inc OXM shares rose 9.3 percent to $63.16. Oxford reported upbeat earnings for its second quarter, but sales missed expectations. The company also issued a strong outlook for the third quarter.
- Yogaworks Inc YOGA shares gained 7.6 percent to $3.55.
- Dr.Reddy's Laboratories Ltd (ADR) RDY shares rose 7.4 percent to $34.57 after gaining 2.06 percent on Thursday.
- Lululemon Athletica inc. LULU shares surged 7.1 percent to $61.62 after the company reported better-than-expected results for its second quarter and raised its FY17 outlook.
- Nutanix Inc NTNX gained 5.8 percent to $23.27 after the company reported strong Q4 results.
- Minerva Neurosciences Inc NERV rose 5 percent to $6.35. Citi initiated coverage on Minerva Neurosciences with a Buy rating.
- Gerdau SA (ADR) GGB climbed 4.3 percent to $3.87. JP Morgan upgraded Gerdau from Neutral to Overweight.
- Gap Inc GPS shares rose 3 percent to $24.28. Citi upgraded Gap from Sell to Neutral.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: NewsIntraday UpdateMarketsAnalyst RatingsMoversApparel, Accessories & Luxury GoodsConsumer DiscretionaryTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
